Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
his study aims to establish reference values and examine the reliability of handgrip strength assessment using a digital dynamometer (VALD DynaMo) in healthy adolescents.
Participants will undergo standardized strength evaluations of upper and lower limbs, following international testing guidelines.
Descriptive variables such as age, sex, height, weight, hand dominance, and physical activity level will also be recorded.
The results will contribute to developing normative data and validating the use of portable dynamometry for musculoskeletal health assessment, with potential future applications in clinical populations.
Muscle strength is a key indicator of musculoskeletal health and functional capacity across the lifespan. Handgrip strength, in particular, is widely recognized as a simple and reliable marker of overall strength and health status.
However, normative reference values vary across populations, and limited data exist for adolescents in local or regional contexts.
This observational study will collect handgrip and lower limb strength data using the VALD DynaMo portable dynamometer. The measurements will follow standardized testing positions (American Society of Hand Therapists protocol) to ensure reliability and comparability.
The project will also serve as a pilot for future research on populations with musculoskeletal, neurological, or oncological conditions, where muscle strength is often compromised.
Participation is voluntary, non-invasive, and without associated risk. All data will be anonymized and stored securely for research purposes only.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy Adolescent Group | A single group of healthy adolescents will participate in the study. Each participant will undergo standardized assessments of upper and lower limb muscle strength using digital dynamometry. No treatment or intervention will be applied. |
| |
| Clinical Population Group (Future Recruitment) | This group may include participants with musculoskeletal, neurological, or oncological conditions in future phases of the study. The same standardized dynamometry protocol will be applied to compare muscle strength profiles and assess the applicability of the measurement tools in clinical populations. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Muscle Strength Assessment using Digital Handheld Dynamometry (VALD Dynamo®) | Diagnostic Test | All participants (healthy or clinical) will perform standardized muscle strength tests using the VALD Dynamo® digital dynamometer. For upper limb assessments, the protocol will follow the American Society of Hand Therapists (ASHT) recommendations (shoulder neutral, elbow 90°, forearm neutral, wrist 0-30° extension, 0-15° ulnar deviation). Lower limb tests will include validated isometric protocols for major muscle groups (quadriceps, hamstrings, hip abductors/adductors). Each test will include three maximal voluntary contractions (3 seconds each) with 60 seconds of rest between trials. Data will be used to analyze intra- and inter-session reliability, normative reference values, and potential clinical applicability. |
| Measure | Description | Time Frame |
|---|---|---|
| Maximal Isometric Muscle Strength (Handgrip and Lower Limb) | Peak isometric force (in Newtons or kilograms) recorded using a VALD Dynamo® handheld digital dynamometer. Measurements will follow standardized positioning protocols recommended by the American Society of Hand Therapists (ASHT) for upper limb and by recent literature for lower limb testing. Each participant will perform three maximal voluntary contractions per muscle group, with the highest value recorded for analysis. Unit of Measure: Newtons (N) or Kilograms. | Single testing session (baseline). |
| Measure | Description | Time Frame |
|---|---|---|
| Test-Retest Reliability of Muscle Strength Measures. Maximal Isometric Muscle Strength Handgrip | VALD Dynamo®: Assessment of intra-rater reliability of dynamometry results across two sessions separated by 7-14 days, in a subset of participants and intra-session. Reliability will be quantified using Intraclass Correlation Coefficients (ICC), Standard Error of Measurement (SEM), and Coefficient of Variation (CV). (%) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The study will include healthy adolescent students (initially aged 15-16 years) from local educational centers collaborating with the University of Extremadura.
Participants will undergo non-invasive strength assessments using handheld dynamometry to establish normative reference values.
In future phases, the study population may be expanded to include clinical cohorts (e.g., patients with musculoskeletal, neurological, or oncological pathologies) to explore the applicability of dynamometry in clinical assessment and rehabilitation contexts.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Facultad de Medicina y Ciencias de la Salud. Avenida de Elvas s/n | Badajoz | Badajoz | 06006 | Spain |
Not provided
Not provided
Not provided
Not provided
|
| Two sessions separated by 7-14 days. |
| Descriptive Anthropometric and Activity Variables | Age, sex, height, body weight, body mass index (BMI), dominant hand, and self-reported physical activity level (frequency and type of sport practiced per week). These variables will be analyzed to explore associations with muscle strength outcomes. | Collected at baseline (single session). |
| Clinical Applicability (Optional Future Arm). Maximal Isometric Muscle Strength (Handgrip) | Comparison of muscle strength (kg) profiles between healthy participants and individuals with musculoskeletal, neurological, or oncological conditions (if included in later phases). Outcomes will explore between-group differences and responsiveness of the measurement tool in clinical contexts. | To be determined in future phases |